Try our beta test site
7 studies found for:    baxter h1n1
Show Display Options
Rank Status Study
1 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
2 Completed Swine Flu (Influenza A H1N1) Follow on Vaccine Study
Condition: Influenza
Intervention: Drug: Seasonal Flu vaccine
3 Completed Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine
Conditions: Influenza;   Pandemic Influenza
Intervention: Biological: H1N1 Pandemic Influenza Vaccine (whole virion, Vero Cell-derived, inactivated)
4 Completed A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
Conditions: Influenza;   Pandemic Influenza
Interventions: Biological: H1N1 pandemic influenza vaccine (whole virion, Vero cell-derived, inactivated);   Biological: Seasonal trivalent influenza vaccine (licensed) for the season 2010/2011
5 Completed A/H1N1 Immunogenicity and Safety in Adults
Conditions: Influenza;   Pandemic Influenza
Intervention: Biological: H1N1 pandemic influenza vaccine (whole virion, Vero Cell-derived, inactivated)
6 Active, not recruiting Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults
Condition: Human Influenza
Interventions: Biological: Recombinant Influenza Vaccine;   Biological: Inactivated Influenza Vaccine
7 Completed
Has Results
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
Condition: Influenza
Interventions: Biological: FluBlok Influenza Vaccination;   Biological: TIV (Fluzone) Influenza Vaccination

Study has passed its completion date and status has not been verified in more than two years.